BJMO - volume 12, issue 7, november 2018
C. Vulsteke MD, PhD, M. del Pilar Ortega Arevalo , Ir C. Mouton MBA, K. Stam , R. Goethals , F. Ameye MD, PhD, C. Populaire , M. Peeters MD, PhD, P. Verdonck
Keeping up with the rising amount of clinical data, guidelines and approvals of new antineoplastic drugs is a major challenge for every oncologist. Artificial intelligence promises to address this and to revolutionise health care and cancer treatment. What is the current state of artificial intelligence for the oncologist, and is it ready for prime time? In this article, the current, available tools of artificial intelligence are highlighted, which try to take a privileged role in the daily practice of the oncologist.
(BELG J MED ONCOL 2018;12(7)330–333)